Tumor Acidosis Boosts Antibody-Driven Cytotoxic Potential of Neutrophils
Cells · 2026
DOI: 10.3390/cells15181663 ↗At a glance
Journal article in Cells, 2026. Written by Tosca Holtrop and 9 co-authors. Institution: Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands. Major MEDLINE topics: Neutrophils, Antibody-Dependent Cell Cytotoxicity, Acidosis, Neoplasms. 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Oncode Accelerator, Stichting Villa Joep, Dutch Cancer Society.
Abstract (original language)
The acidic tumor microenvironment (pH 6.3–7.1) influences immune cell function, yet its impact on antibody-mediated killing remains poorly understood. While natural killer (NK) cells lose their spontaneous tumor-killing ability in acidic conditions, the effect on IgG-mediated killing is unexplored. Neutrophils, key effector cells in IgA immunotherapy, respond to pH changes by delayed apoptosis and show impaired bacterial killing. In this study, we investigated how extracellular acidity affects immune cell function and modulates antibody-dependent cytotoxicity by neutrophils and peripheral blood mononuclear cells (PBMCs) across multiple in vitro tumor models. Contrary to expectations, acidity significantly enhanced both IgG- and IgA-mediated tumor cell killing by neutrophils, while IgG-mediated antibody-dependent cellular cytotoxicity (ADCC) by PBMCs had a varying impact. This increased neutrophil activity was accompanied by elevated IgA-driven trogocytosis, while protumor reactive oxygen species production and neutrophil extracellular trap (NET) formation were suppressed. Cytokine profiling and Western blot analysis revealed increased Leukotriene B4 (LTB4) secretion and extracellular signal-regulated kinase (Erk) signaling, supporting enhanced neutrophil recruitment and activation in acidic conditions. Our findings reveal that, unlike other immune subsets, neutrophils maintain or even boost antibody-mediated effector functions in the acidic tumor microenvironment, providing new insight into neutrophil biology in tumors and supporting further investigation of neutrophil-targeted antibody immunotherapies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
- Division of Stem Cell Transplantation and Immunotherapy, University Medical Center Schleswig-Holstein, 24105 Kiel, Germany.
ORCID profiles: Tosca Holtrop, Ida C van der Peet, Tineke Kardol-Hoefnagel, Kevin Budding, Jeanette H W Leusen, Patricia A Olofsen
Funding
- Oncode Accelerator
- Stichting Villa Joep
- Dutch Cancer Society
- University Medical Center Utrecht
- Villa Joep Foundation
- UMC Utrecht Starting
Cite
APA
Holtrop, T., van der Peet, I. C., Hendriks, I. S. T., Kardol-Hoefnagel, T., Schol, R. B., Lustig, M., Budding, K., Leusen, J. H. W., Olofsen, P. A., & Tsioumpekou, M. (2026). Tumor Acidosis Boosts Antibody-Driven Cytotoxic Potential of Neutrophils. Cells. https://doi.org/10.3390/cells15181663
Vancouver
Holtrop T, van der Peet IC, Hendriks IST, Kardol-Hoefnagel T, Schol RB, Lustig M, et al. Tumor Acidosis Boosts Antibody-Driven Cytotoxic Potential of Neutrophils. Cells. 2026. doi:10.3390/cells15181663
BibTeX
@article{Holtrop2026,
author = {Holtrop, Tosca and van der Peet, Ida C and Hendriks, Ilona S T and Kardol-Hoefnagel, Tineke and Schol, Robin B and Lustig, Marta and Budding, Kevin and Leusen, Jeanette H W and Olofsen, Patricia A and Tsioumpekou, Maria},
title = {Tumor Acidosis Boosts Antibody-Driven Cytotoxic Potential of Neutrophils},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15181663}
}
EUVIMED